Switch theme
Sign up to access all valuation multiples
WELL Health Technologies Corp is a practitioner-focused digital healthcare company. It has seven reportable segments that are grouped into three key business units: Canadian Patient Services that includes Primary and Specialized MyHealth. WELL Health USA Patient Services includes Primary Circle Medica, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing and SaaS and Technology Services. It generates the majority of its revenue from Well Health USA Patient and Provider Services unit.
2010
3.2K+
LTM Revenue $810M
LTM EBITDA $77.2M
$1.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
WELL Health has a last 12-month revenue (LTM) of $810M and a last 12-month EBITDA of $77.2M.
In the most recent fiscal year, WELL Health achieved revenue of $664M and an EBITDA of $84.3M.
WELL Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See WELL Health valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $810M | XXX | $664M | XXX | XXX | XXX |
| Gross Profit | $345M | XXX | $262M | XXX | XXX | XXX |
| Gross Margin | 43% | XXX | 39% | XXX | XXX | XXX |
| EBITDA | $77.2M | XXX | $84.3M | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 13% | XXX | XXX | XXX |
| EBIT | $17.6M | XXX | -$22.2M | XXX | XXX | XXX |
| EBIT Margin | 2% | XXX | -3% | XXX | XXX | XXX |
| Net Profit | $15.3M | XXX | $23.5M | XXX | XXX | XXX |
| Net Margin | 2% | XXX | 4% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $154M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, WELL Health's stock price is CAD 4 (or $3).
WELL Health has current market cap of CAD 1.0B (or $749M), and EV of CAD 1.4B (or $1.0B).
See WELL Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.0B | $749M | XXX | XXX | XXX | XXX | $0.13 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, WELL Health has market cap of $749M and EV of $1.0B.
WELL Health's trades at 1.5x EV/Revenue multiple, and 12.1x EV/EBITDA.
Equity research analysts estimate WELL Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
WELL Health has a P/E ratio of 49.0x.
See valuation multiples for WELL Health and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $749M | XXX | $749M | XXX | XXX | XXX |
| EV (current) | $1.0B | XXX | $1.0B | XXX | XXX | XXX |
| EV/Revenue | 1.3x | XXX | 1.5x | XXX | XXX | XXX |
| EV/EBITDA | 13.2x | XXX | 12.1x | XXX | XXX | XXX |
| EV/EBIT | 57.8x | XXX | -45.8x | XXX | XXX | XXX |
| EV/Gross Profit | 2.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | 49.0x | XXX | 31.8x | XXX | XXX | XXX |
| EV/FCF | 22.8x | XXX | -210.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialWELL Health's last 12 month revenue growth is 30%
WELL Health's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
WELL Health's rule of 40 is 45% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
WELL Health's rule of X is 85% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for WELL Health and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 30% | XXX | 29% | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 13% | XXX | XXX | XXX |
| EBITDA Growth | 79% | XXX | 31% | XXX | XXX | XXX |
| Rule of 40 | 45% | XXX | 43% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 85% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 9% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 43% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
WELL Health acquired XXX companies to date.
Last acquisition by WELL Health was XXXXXXXX, XXXXX XXXXX XXXXXX . WELL Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was WELL Health founded? | WELL Health was founded in 2010. |
| Where is WELL Health headquartered? | WELL Health is headquartered in Canada. |
| How many employees does WELL Health have? | As of today, WELL Health has 3.2K+ employees. |
| Who is the CEO of WELL Health? | WELL Health's CEO is Mr. Hamed Shahbazi. |
| Is WELL Health publicy listed? | Yes, WELL Health is a public company listed on TSE. |
| What is the stock symbol of WELL Health? | WELL Health trades under WELL ticker. |
| When did WELL Health go public? | WELL Health went public in 2012. |
| Who are competitors of WELL Health? | Similar companies to WELL Health include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of WELL Health? | WELL Health's current market cap is $749M |
| What is the current revenue of WELL Health? | WELL Health's last 12 months revenue is $810M. |
| What is the current revenue growth of WELL Health? | WELL Health revenue growth (NTM/LTM) is 30%. |
| What is the current EV/Revenue multiple of WELL Health? | Current revenue multiple of WELL Health is 1.3x. |
| Is WELL Health profitable? | Yes, WELL Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of WELL Health? | WELL Health's last 12 months EBITDA is $77.2M. |
| What is WELL Health's EBITDA margin? | WELL Health's last 12 months EBITDA margin is 10%. |
| What is the current EV/EBITDA multiple of WELL Health? | Current EBITDA multiple of WELL Health is 13.2x. |
| What is the current FCF of WELL Health? | WELL Health's last 12 months FCF is $44.6M. |
| What is WELL Health's FCF margin? | WELL Health's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of WELL Health? | Current FCF multiple of WELL Health is 22.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
